Zacks Investment Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $293K | Sell |
751
-37
| -5% | -$15.6K | ﹤0.01% | 596 |
|
|
2026
Q1 | $373K | Sell |
788
-578
| -42% | -$291K | ﹤0.01% | 541 |
|
|
2025
Q4 | $638K | Sell |
1,366
-145
| -10% | -$67.3K | 0.01% | 464 |
|
|
2025
Q3 | $644K | Buy |
+1,511
| New | +$586K | 0.01% | 455 |
|
|
2025
Q1 | – | Sell |
-842
| Closed | -$253K | – | 696 |
|
|
2024
Q4 | $253K | Sell |
842
-61,275
| -99% | -$21.4M | ﹤0.01% | 590 |
|
|
2024
Q3 | $25.2M | Buy |
62,117
+1,942
| +3% | +$711K | 0.22% | 118 |
|
|
2024
Q2 | $19.3M | Buy |
60,175
+4,073
| +7% | +$1.32M | 0.22% | 113 |
|
|
2024
Q1 | $18.7M | Buy |
+56,102
| New | +$17.1M | 0.2% | 119 |
|
|
2023
Q4 | – | Sell |
-21,097
| Closed | -$5.19M | – | 641 |
|
|
2023
Q3 | $5.19M | Buy |
21,097
+1,510
| +8% | +$413K | 0.07% | 178 |
|
|
2023
Q2 | $5.94M | Buy |
+19,587
| New | +$5.45M | 0.07% | 172 |
|
|
2022
Q1 | – | Sell |
-18,830
| Closed | -$4.84M | – | 619 |
|
|
2021
Q4 | $4.84M | Buy |
18,830
+490
| +3% | +$120K | 0.07% | 189 |
|
|
2021
Q3 | $4.45M | Buy |
18,340
+1,241
| +7% | +$303K | 0.07% | 194 |
|
|
2021
Q2 | $3.54M | Sell |
17,099
-14,284
| -46% | -$2.91M | 0.06% | 213 |
|
|
2021
Q1 | $5.91M | Buy |
+31,383
| New | +$5.53M | 0.11% | 161 |
|
|
2019
Q1 | – | Sell |
-3,338
| Closed | -$415K | – | 559 |
|
|
2018
Q4 | $415K | Buy |
3,338
+1,452
| +77% | +$195K | 0.01% | 454 |
|
|
2018
Q3 | $262K | Buy |
+1,886
| New | +$235K | 0.01% | 473 |
|
|
2017
Q3 | – | Sell |
-25,418
| Closed | -$2.22M | – | 617 |
|
|
2017
Q2 | $2.22M | Sell |
25,418
-1,712
| -6% | -$145K | 0.05% | 222 |
|
|
2017
Q1 | $2.41M | Buy |
27,130
+9,419
| +53% | +$785K | 0.06% | 201 |
|
|
2016
Q4 | $1.31M | Sell |
17,711
-7,657
| -30% | -$573K | 0.04% | 277 |
|
|
2016
Q3 | $1.92M | Sell |
25,368
-1,866
| -7% | -$143K | 0.05% | 213 |
|
|
2016
Q2 | $2.1M | Buy |
27,234
+8,991
| +49% | +$710K | 0.06% | 191 |
|
|
2016
Q1 | $1.42M | Buy |
18,243
+5,637
| +45% | +$394K | 0.05% | 258 |
|
|
2015
Q4 | $853K | Sell |
12,606
-2,876
| -19% | -$201K | 0.03% | 324 |
|
|
2015
Q3 | $1.2M | Sell |
15,482
-6,099
| -28% | -$540K | 0.04% | 263 |
|
|
2015
Q2 | $1.96M | Buy |
21,581
+1,256
| +6% | +$101K | 0.06% | 183 |
|
|
2015
Q1 | $1.53M | Buy |
20,325
+1,311
| +7% | +$94.2K | 0.05% | 213 |
|
|
2014
Q4 | $1.4M | Buy |
19,014
+11,591
| +156% | +$815K | 0.05% | 213 |
|
|
2014
Q3 | $523K | Buy |
+7,423
| New | +$491K | 0.02% | 398 |
|
Other funds holding HCA
Zacks Investment Management's HCA Position: Q2 2026 in Review
Zacks Investment Management reduced its HCA Healthcare (HCA) stake by 4.7% in Q2 2026, selling an estimated $15.6K and leaving 751 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #596.
Zacks Investment Management first reported a position in HCA in Q3 2014 and has held it in 28 quarters since. The position peaked at $25.2M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Zacks Investment Management held 751 shares of HCA Healthcare worth $293K as of Q2 2026.
- Zacks Investment Management sold 37 HCA Healthcare shares in Q2 2026, an estimated $15.6K.
- HCA Healthcare made up ﹤0.01% of Zacks Investment Management's portfolio in Q2 2026, its #596 holding.
- Zacks Investment Management first reported a position in HCA Healthcare in Q3 2014 and has held it in 28 quarters since.
- Zacks Investment Management's HCA Healthcare position peaked at $25.2M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.